{
    "status": "OK",
    "copyright": "Copyright (c) 2025 The New York Times Company. All Rights Reserved.",
    "response": {
        "docs": [
            {
                "abstract": "Many Wall Street analysts and heart specialists are lukewarm about the drug, which has shown mixed results in clinical trials.",
                "web_url": "https://www.nytimes.com/2015/04/16/business/fda-approves-amgen-drug-to-treat-heart-failure.html",
                "snippet": "Many Wall Street analysts and heart specialists are lukewarm about the drug, which has shown mixed results in clinical trials.",
                "lead_paragraph": "The Food and Drug Administration on Wednesday approved a drug to treat chronic heart failure that may help keep patients out of the hospital.",
                "print_section": "A",
                "print_page": "19",
                "source": "The New York Times",
                "multimedia": [],
                "headline": {
                    "main": "F.D.A. Approves Amgen Drug to Treat Heart Failure",
                    "kicker": null,
                    "content_kicker": null,
                    "print_headline": "F.D.A. Approves Drug to Treat Heart",
                    "name": null,
                    "seo": null,
                    "sub": null
                },
                "keywords": [
                    {
                        "name": "subject",
                        "value": "Heart",
                        "rank": 2,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "Food and Drug Administration",
                        "rank": 3,
                        "major": "N"
                    },
                    {
                        "name": "subject",
                        "value": "Drugs (Pharmaceuticals)",
                        "rank": 4,
                        "major": "N"
                    },
                    {
                        "name": "organizations",
                        "value": "Amgen Inc",
                        "rank": 5,
                        "major": "N"
                    }
                ],
                "pub_date": "2015-04-15T22:17:19+0000",
                "document_type": "article",
                "news_desk": "Business",
                "section_name": "Business Day",
                "byline": {
                    "original": "By Andrew Pollack",
                    "person": [
                        {
                            "firstname": "Andrew",
                            "middlename": null,
                            "lastname": "Pollack",
                            "qualifier": null,
                            "title": null,
                            "role": "reported",
                            "organization": "",
                            "rank": 1
                        }
                    ],
                    "organization": null
                },
                "type_of_material": "News",
                "_id": "nyt://article/f288e090-b0e5-50e3-936d-956ac1f4ed06",
                "word_count": 633,
                "uri": "nyt://article/f288e090-b0e5-50e3-936d-956ac1f4ed06"
            }
        ],
        "meta": {
            "hits": 1,
            "offset": 0,
            "time": 6
        }
    }
}